[ET Net News Agency, 15 April 2024] HIGHTIDE-B (02511) rose 23.5% to HK$5.31, breaking
above the 10-D SMA of HK$5.252.
It hits an intra-day high of HK$5.39, and an intra-day low of HK$4.03. The total shares
traded was 705,000, with a value of HK$3.2m. The active buy/sell ratio is 72:28, with net
buying turnover of HK$1.33m. MORGAN STANLEY HK SEC accounts for greatest net responsive
buying turnover of HK$32,075, with volume weighted average price of HK$4.257. FUTU SEC
INT'L accounts for greatest net responsive selling turnover of HK$156,103, with volume
weighted average price of HK$4.595. The stock has risen a combined 24.9% over the past 2
consecutive trading days.
Basic Information
=================
-----------------------------------
Nominal 5.310 % Chg +23.49%
High 5.390 Low 4.030
Shares Tr 705,000 Turnover 3.2m
10-D SMA 5.252 %H.V 114.493
20-D SMA 5.938 VWAP 4.534
50-D SMA 8.805 RSI14 36.123
-----------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 72:28, with net buying
turnover of HK$1.33m, rising a combined 24.9% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
HIGHTIDE-B (02511) 5.31 +23.49
GENSCRIPT BIO (01548) 12.14 -4.86
INNOVENT BIO (01801) 35.80 -4.15
EVEREST MED-B (01952) 24.65 -5.74
LAEKNA-B (02105) 7.91 +64.45
SIRNAOMICS-B (02257) 7.99 +22.92
WUXI BIO (02269) 13.66 -1.73
TIGERMED (03347) 32.40 +0.47
AKESO (09926) 48.10 -2.83
REMEGEN (09995) 29.10 -9.77
---------------------------------------------
(ed)